SCHEMBL4435660

SCHEMBL4435660

Fc1ccc(Cl)c(-c2nc3c(Cl)cccc3cc2CCNc2ncnc3[nH]cnc23)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 11/20 0.37
LMNA P02545 5/20 0.37
HTT P42858 4/20 0.37
MAPK1 P28482 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
CLK4 Q9HAZ1 4/20 0.34
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2D6 P10635 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
MAP4K4 O95819 2/20 0.34
AURKA O14965 1/20 0.34
DAPK3 O43293 1/20 0.34
JAK2 O60674 1/20 0.34
PRKD3 O94806 1/20 0.34
PAK4 O96013 1/20 0.34
ABL1 P00519 1/20 0.34
LCK P06239 1/20 0.34
CSF1R P07333 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4433726 0.94 HTT (0.37) PIK3CDLMNAHTTMAPK1SMN1; SMN2
SCHEMBL4178542 0.91 PIK3CD (0.40) PIK3CDLMNAHTTCLK4MAP4K4
SCHEMBL4443103 0.88 LMNA (0.40) PIK3CDLMNAHTTMAPK1SMN1; SMN2
SCHEMBL4435767 0.88 MAP4K4 (0.40) PIK3CDLMNAHTTMAPK1SMN1; SMN2
SCHEMBL4429984 0.88 PIK3CD (0.37) PIK3CDLMNAHTTMAPK1SMN1; SMN2
SCHEMBL4431296 0.87 PIK3CD (0.36) PIK3CDLMNAHTTMAPK1SMN1; SMN2
SCHEMBL4443357 0.86 PIK3CD (0.40) PIK3CDLMNAHTTMAPK1SMN1; SMN2
SCHEMBL4434206 0.85 HTT (0.38) PIK3CDLMNAHTTMAPK1SMN1; SMN2
SCHEMBL4436584 0.85 CLK4 (0.34) PIK3CDLMNAHTTMAPK1SMN1; SMN2
SCHEMBL4182144 0.85 MEN1 (0.38) PIK3CDLMNAHTTCLK4MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137186-A1 HETEROCYCLIC COMPOUNDS AND THEIR USES Amgen Inc. (US) 2009-12-30 EP disclosed
WO-2008118468-A1 HETEROCYCLIC COMPOUNDS AND THEIR USES AMGEN INC. (US) 2008-10-02 WO disclosed